Defibrillators Market Size, Share, Growth Report 2030

Defibrillators Market

Defibrillators Market By Product (Implantable Cardioverter Defibrillators and External Defibrillators), By End User (Hospitals, Clinics and Cardiac Centers, Prehospital Care Settings, Public Access Markets, Home Care Settings and Alternate Care Facilities) and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Category: Medical Device Report Format : PDF Pages: 160 Report Code: ZMR-982 Published Date: Oct-2021 Status : Published

The global Defibrillators market accounted for USD 9,714.6 Million in 2020 and is expected to reach USD 12,552.2 Million by 2028, growing at a CAGR of 3.5% from 2021 to 2028.

Defibrillators Market: Overview

The global Defibrillators market accounted for USD 9,714.6Million in 2020 and is expected to reach USD 12,552.2 Million by2028, growing at a CAGR of 3.5% from 2021 to 2028.

Defibrillators can be simply described as electronic devices that deliver an electric shock, of high energy, to the heart of an individual, who went into cardiac arrest. They restore the normal cardiac rhythm of the heart. They are predominantly used to correct and prevent an arrhythmia, which can be simply defined as a heartbeat that is too slow or too fast. There are several types of defibrillators and based on their type, they show a different modes of operation.

Cardiovascular diseases have risen the morbidity rate significantly. The increased morbidity rate is one of the key factors that is augmenting the global defibrillators market. The ability of defibrillators to efficiently control arrhythmias, for extended periods, will drive the growth of the Defibrillators market, during the forecast period.

Global Defibrillators Market SizeRequest Free Sample

COVID-19 Impact Analysis

Before the COVID-19 pandemic, companies in the defibrillators market were expanding at a steady pace. However, during the pandemic, the players in the market took a sharp hit. This can be accredited to the worldwide lockdown and the widespread infection rate of the virus.

Due to the lockdown, the cardiac procedures that were classified as elective were pushed forward, indefinitely. Additionally, hospitals did not take on patients for surgical procedures due to the high risk of infection. All these factors had a cumulative impact on the Defibrillators market, which declined significantly.

However, the pandemic also highlighted the significance of health awareness. Furthermore, Defibrillators will be used in severe cases of Covid infection, to help patients who undergo cardiac arrest. This will enhance the defibrillators market, in the coming years.

Defibrillators Market: Growth Factors

Increased health awareness, changing demographics, and the rising prevalence of cardiovascular diseases are some of the key factors that advance the defibrillators market.

The world population, currently, is struggling with-communicable diseases such as cardiovascular diseases, obesity-related disorders, diabetes, and hypertension among others. These diseases have a negative impact on the cardiac health of individuals. Owing to this, there is an increase in cardiac surgeries and procedures. This will drive the growth of the defibrillators market. Furthermore, changing demographics have increased the population of aging citizens. This further increases the demand and need for cardiac procedures.

Subsequently, the presence of a large number of developing and developed economies, worldwide, has resulted in economic growth and high disposable incomes. Owing to this, the expenditure power of consumers has risen, which will further enhance the defibrillators market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and MiddleEast & Africa, and the Rest of the World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Companies Covered Boston Scientific Corporation, Medtronic Plc, AbbottLaboratories, Nihon Kohden Corporation, Koninklijke Philips N.V., Biotronik, LivaNova Plc, Mediana Co. Ltd., BPL Medical Technologies and Schiller AG among others
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Product Segment Analysis Preview

The Implantable Cardioverter Defibrillators (ICDs) segment held a share of over 36% in 2020, becoming the most dominant segment, globally and it is expected to maintain its dominance, during the forecast period. This dominance can be credited to several factors such as increasing technological developments, rising research and development activities, and the advantages linked with the usage of ICD.

Owing to economic growth, large investments for research and development activities, in the healthcare segment, and technological developments, ICDs have been modified and developed, to provide value to the end-users, efficiently. Due to this, they acquire a major part of the global Defibrillators market.

Subsequently, the External Defibrillators segment holds a substantial share of the market. This is attributable to the features of Wearable Cardioverter Defibrillators (WCDs) and Automated External Defibrillators (AEDs). Due to their automation, they can be easily operated, with convenience.

Global Defibrillators Market ShareRequest Free Sample

End User Segment Analysis Preview

The Hospitals, Clinics, and Cardiac Centers segment is anticipated to reach a CAGR of over 2.5% between 2021 and 2028. This is attributable to the immense demand and usage of defibrillators at Hospitals and Clinics.  

Defibrillators are utilized for a multitude of cardiac surgeries and procedures. They have applications outside of cardiac surgery as well. With the rising healthcare segment and increased expenditure power, there has been a surge in elective procedures and surgeries. This, in turn, enhances the use of Defibrillators at Hospitals. Additionally, sedentary lifestyles increase the burden of cardiovascular diseases. Subsequently, the Public Access Markets segment holds a substantial share of the Defibrillators market. This is attributable to the increased prevalence of heart conditions. Setting up of Defibrillators in Public places helps with cardiac arrest occurrences at Public locations.

Defibrillators Market: Regional Analysis Preview

The North American region accounted for a share of over 33% in 2020. This is attributable to various factors such as innovations in the field of healthcare and devices, enhanced obesity rate,well-established and advanced healthcare system, and high prevalence of cardiovascular diseases, in the region.

Developed economies like the US and Canada have well-established and highly advanced healthcare systems. Due to this, they have a large number of investments in the medical industry, for developing and innovating surgical procedures. This advances the defibrillators market in the region. Additionally, the obesity rate in the region is on the rise. This creates health problems for its residents and increases their reliability on medical procedures. Furthermore, the region has a high prevalence rate of cardiovascular diseases. This, in turn, enhances the growth of the defibrillators market, in the region.

Global Defibrillators Market Regional AnalysisRequest Free Sample

The Asia Pacific region is anticipated to grow with a CAGR of over 6.7% between 2021 and 2028. This can be accredited to several factors that include economic development, growing population, advancing healthcare segment, and changing demographics, in the region.

Countries like Japan, China, and India have rapidly growing healthcare systems. Additionally, governments across various countries in the Asia Pacific region are taking initiatives and making huge investments in their healthcare system, to enhance their medical care and facilities.

Furthermore, the region is undergoing a change in its demographics which has increased the population of aging citizens. Subsequently, there is increased health awareness and enhanced expenses in the healthcare and medical industry, in the region. This will further enhance the regional Defibrillators market. 

Defibrillators Market: Key Players & Competitive Landscape

Some of the key players in the Defibrillators market are BostonScientific Corporation, Medtronic Plc, Abbott Laboratories, NihonKohden Corporation, Koninklijke Philips N.V., Biotronik, LivaNovaPlc, Mediana Co. Ltd., BPL Medical Technologies and Schiller among others.

The global Defibrillators Market is segmented as follows:

By Product

  • Implantable Cardioverter Defibrillators (ICDs)
    • Transvenous Implantable Cardioverter Defibrillators(T-ICDs)
    • Subcutaneous Implantable Cardioverter Defibrillators(S-ICDs)
    • Cardiac Resynchronization Therapy Defibrillator (CRT-D)
  • External Defibrillators
    • Manual External Defibrillators (MEDs)
    • Automated External Defibrillators (AEDs)
    • Wearable Cardioverter Defibrillators (WCDs)

By End User

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The global Defibrillators Market was valued at USD 9,714.6 Million in 2020.

The global Defibrillators Market is expected to reach USD 12,552.2 Million by 2028, growing at a CAGR of 3.5% between 2021 to 2028.

Some of the key factors driving the global Defibrillators Market growth are increased health awareness, changing demographics and rising prevalence of non-communicable diseases

North America region held a substantial share of the Defibrillators Market in 2020. This surge can be credited to innovations in the field of healthcare and devices, enhanced obesity rate, well-established and advanced healthcare system and high prevalence of cardiovascular diseases, in the region.

Some of the major companies operating in the Defibrillators Market are Boston Scientific Corporation, Medtronic Plc, Abbott Laboratories, Nihon Kohden Corporation, Koninklijke Philips N.V., Biotronik, LivaNova Plc, Mediana Co. Ltd., BPL Medical Technologies and Schiller AG among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed